Philip Bruggmann
A5030105607- Hepatitis C virus research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- HIV, Drug Use, Sexual Risk
- Alcohol Consumption and Health Effects
- HIV/AIDS Research and Interventions
- Hepatitis Viruses Studies and Epidemiology
- HIV/AIDS drug development and treatment
- Hormonal and reproductive studies
- Drug-Induced Hepatotoxicity and Protection
- Consumer behavior in food and health
- Liver Disease and Transplantation
- Health and Medical Studies
- Smoking Behavior and Cessation
- Healthcare Systems and Practices
- Chronic Lymphocytic Leukemia Research
- Health, Medicine and Society
- Opioid Use Disorder Treatment
- Obesity, Physical Activity, Diet
- Substance Abuse Treatment and Outcomes
- Pharmacology and Obesity Treatment
- Adolescent Sexual and Reproductive Health
- Pneumocystis jirovecii pneumonia detection and treatment
- Health Promotion and Cardiovascular Prevention
- Economic and Business Studies
Addiction Switzerland
2015-2025
University Hospital of Zurich
2019-2025
University of Zurich
2016-2024
University of Fribourg
2024
University of Basel
2024
Sorbonne Université
2024
University of Bern
2024
Centre universitaire de médecine générale et santé publique, Lausanne
2024
University Hospital of Bern
2024
University of Lausanne
2024
Summary The disease burden of hepatitis C virus ( HCV ) is expected to increase as the infected population ages. A modelling approach was used estimate total number viremic infections, diagnosed, treated and new infections in 2013. In addition, model change progression mortality 2013–2030. Finally, expert panel consensus capture current treatment practices each country. Using today's paradigm, projected decline or remain flat all countries studied. However, same time period, individuals with...
Electronic nicotine-delivery systems - also called e-cigarettes are used by some tobacco smokers to assist with quitting. Evidence regarding the efficacy and safety of these is needed.
Summary The number of hepatitis C virus ( HCV ) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used forecast two treatment scenarios: (i) the impact increased efficacy keeping treated patients constant and (ii) increasing rate. This analysis suggests that successful diagnosis a small proportion can contribute significantly reduction burden in countries studied. largest ‐related morbidity mortality occurs when combined higher...
In the developed world, majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). The burden HCV-related liver disease in this group is increasing, but treatment uptake PWID remains low. Among PWID, there are a number barriers to care that should be considered systematically addressed, these not exclude from HCV treatment. Furthermore, it has been clearly demonstrated safe effective across broad range multidisciplinary healthcare settings....
People who inject drugs (PWID) represent the core of hepatitis C virus (HCV) epidemic in many countries. HCV transmission continues among PWID, despite evidence demonstrating that high coverage combined harm reduction strategies, such as needle syringe programs (NSP) and opioid substitution treatment (OST), can be effective reducing risk transmission. Among infected individuals, HCV-related morbidity mortality to grow is accompanied by major public health, social economic burdens. Despite...
The non-medical use of anabolic androgenic steroids for the improvement aesthetic and sports performance purposes has become a global substance disorder, particularly among men in recreational sports. Health outcomes people who are using may be detrimental, yet healthcare services these users scarce. Therefore, aim this project was to conduct quality assurance study evaluate feasibility providing current best clinical practice based on published literature within primary care Zurich...
While the numbers of hepatitis-C-virus (HCV) infections among men who have sex with (MSM) are co-infected human immunodeficiency virus (HIV) on rise, vast evidence for sexual transmission HCV in this population, concerns also been raised regarding HCV-transmission MSM without HIV infection. Therefore, aim study was to estimate prevalence hepatitis C diagnosis Zurich (Switzerland). Participants were recruited from a gay health centre and various locations such as dark rooms, saunas cruising...
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well significant indirect costs. The disease burden caused by the hepatitis virus (HCV) comparable to one human immunodeficiency or tuberculosis. Today, simple detection methods, highly effective easy administer therapies efficient preventative measures are available combat C. Nevertheless, in most countries around world, World Health Organization target of eliminating this infectious its consequences...
People with psychiatric and substance use disorders are more likely to smoke less quit than smokers in the general population. We evaluated efficacy of e-cigarettes for abstinence from tobacco smoking people problems. analyzed data collected larger 'Efficacy, Safety, Toxicology ENDS as an Aid Smoking Cessation' (ESTxENDS) trial (n=1246): intervention group received e-liquids, plus standard-of-care cessation counseling (SOC) 6 months; control SOC a voucher. The primary outcome was...